Results 211 to 220 of about 749,373 (347)
DNA Damage and Repair in Pancreatic Cancer-The Latest Findings. [PDF]
Int J Mol SciKozłowska M +3 more
europepmc +1 more source
Advanced Science, EarlyView.This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang +15 more
wiley +1 more source
Challenges of early detection of pancreatic cancer. [PDF]
J Clin InvestShen MJ, Jamali A, Katona BW.
europepmc +1 more source
Multidisciplinary Management of Pancreatic Cancer [PDF]
, 2015 Margaret A. Tempero
openalex +1 more source
Bisphenol B Exposure Induces Miscarriage by Suppressing Migration/Invasion and Migrasome Formation
Advanced Science, EarlyView.BPB (Bisphenol B) exposure up‐regulates ER (estrogen receptor) levels, enhances its interactions with the lnc‐HZ04 promoter region, and thus promotes ER‐mediated lnc‐HZ04 transcription. Subsequently, lnc‐HZ04 suppresses TCF4 (transcription factor 4)‐mediated PKCA (protein kinase C alpha) transcription and subsequently suppresses migration/invasion and ...
Wenxin Huang +13 more
wiley +1 more source
SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer. [PDF]
Medicina (Kaunas)Akar H +3 more
europepmc +1 more source
K-rasMutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-Analysis [PDF]
, 2014 Jing Yang +16 more
openalex +1 more source
Advanced Science, EarlyView.Triple‐negative breast cancer exhibits variable sensitivity to PRMT5 inhibition. Basal interferon signaling is identified as a key biomarker of response. PARP inhibition with olaparib induces IFN signaling, sensitizing resistant TNBC cells to PRMT5 inhibitors.
Ziwen Zhang +9 more
wiley +1 more source